Corcept Therapeutics | CORT - Ebitda

Aktienkurs
32.32
Täglich Wechseln
0.17 0.53%
Monatlich
-18.45%
Jährlich
-42.30%
Q1 Prognose
31.18




Ebitda Veränderung Datum
Acadia Pharmaceuticals USD 35.76M 447K 2025-09
Alaunos Therapeutics USD -21.02M 1.33M 2021-03
ANI Pharmaceuticals USD 65.36M 5.76M 2025-12
Ardelyx USD 5.57M 17.44M 2025-09
Aurora Cannabis CAD 15.37M 26.8M 2025-09
BioMarin Pharmaceutical USD -24.17M 18.91M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Canopy Growth CAD 16.62M 38.45M 2025-09
Corcept Therapeutics USD 4.2M 6.5M 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Esperion Therapeutics USD -27.51M 9.5M 2023-09
J&J USD 9.52B 389M 2025-09
Knight Therapeutics CAD 15.51M 3.39M 2025-06
Merck USD 8.39B 1.97B 2025-09
Nektar Therapeutics USD -31.81M 70K 2023-09
Novartis USD 5.88B 290M 2025-09
Novartis USD 5.84B 235M 2025-09
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 38.71M 10.65M 2025-12
Pfizer USD 6.08B 351M 2025-09
Supernus Pharmaceuticals USD 48.5M 6.6M 2025-12
TG Therapeutics USD 32.69M 5M 2025-09